Labcorp Announces 2023 Second Quarter Results
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the second quarter ended June 30, 2023, and provided full-year guidance. “We delivered strong results in the quarter, and I’m optimistic about our opportunities for continued…
What’s in a Home: Exploring the Two Types of Home Dialysis Treatments
Home hemodialysis (HHD) and peritoneal dialysis (PD) are both performed at home by the patient, often with the aid of a trained care partner or family member. Both treatments can offer individuals more flexibility and more independence than traditional in-center hemodialysis while also…
Extreme heat, unhealthy air hits Chicago Friday
Chicagoans face a dual threat of deadly heat and unhealthy air Friday, expected to be the hottest day so far this year. Forecasters predict a heat index — a measure of temperature and humidity — that may reach 110 degrees.…
MicroVention Celebrates One-Year Anniversary of FRED™ X Flow Diverter with Over 1,000 Patients Treated Across the U.S.
MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating the one-year anniversary of the company’s FRED™ X Flow Diverter. In close collaboration with physician partners across the United States, over 1,000 patients have been…
Global Medical Tubing Market Analysis Report 2023-2030: Manufacturers Seeking Collaborations to Help Spur Innovative Solutions – ResearchAndMarkets.com
The global medical tubing market size is anticipated to reach USD 19,498.5 million by 2030. The market is expected to expand at a CAGR of 6.0% from 2023 to 2030 The prevalence of respiratory diseases such as asthma, lung cancer,…
KLAS Report Highlights MedSitter as a Leader in Virtual Patient Observation Solutions
MedSitter, a leading virtual patient observation solution received top marks from a KLAS Emerging Solutions Spotlight report released today, which revealed positive customer experiences with MedSitter’s innovative solution. The virtual patient observation market is experiencing significant growth as healthcare organizations look…
CPSI Names Mark V. Anquillare to Board of Directors
CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced that Mark V. Anquillare has joined the CPSI Board of Directors as an independent director. On July 28, 2023, upon the recommendation of the Nominating and Corporate Governance Committee, the Board…
Cybin Announces Overnight Marketed Public Offering of Units
Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to announce that it has launched an overnight marketed public offering of…
Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
Replimune Group, Inc. (NASDAQ:REPL), a clinical stage biotechnology company pioneering the development of a novel portfolio of tumor-directed oncolytic immunotherapies, and Incyte (NASDAQ:INCY), a global biopharmaceutical company, today announced a clinical trial collaboration and supply agreement to study RP1, Replimune’s…
Jemperli (dostarlimab-gxly) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancer
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly) in combination with carboplatin and paclitaxel, followed by Jemperli as a single agent for the treatment of adult patients with primary advanced or recurrent endometrial cancer…
Labcorp OnDemand Offers Menopause Test to Consumers
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it now offers menopause testing through its Labcorp OnDemand digital health platform. Approximately 1.3 million women enter menopause each year. While menopause officially marks the end of a woman’s menstrual cycles,…
Baxter Reports Second-Quarter 2023 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2023. “Baxter’s second-quarter performance reflects ongoing solid demand for our diverse, durable portfolio of medically essential products,” said José (Joe) E. Almeida, chairman, president…